Type 2 diabetic nephropathy has imposed a major type and type 2 diabetic nephropathy in Chinese patients.
although its role cannot be totally excluded in the Asian Results. Patients with type 2 diabetic nephropathy had a population [2] . Studies of other RAS gene polymorhigher frequency of PAI-1 (4G/4G) genotypes than those withphisms did not give conclusive results either [3, 4] . glomerulosclerosis [5] . The exact pathogenesis of ECM Conclusions. These results suggest that the PAI-1 4G/4G accumulation and modeling is unknown, but the fibrinogenotype is associated with an increased risk for type 2 diabetic nephropathy in Chinese patients, which is an independent risk lytic pathway is believed to play an important role [6] .
factor for the development of nephropathy. The PAI-1 4G/4G
One of the key regulators of fibrinolysis in our body is genotype also exhibits a synergistic effect with the ACE D the plasminogen activator (PA)/plasmin system. Plasallele on development of diabetic nephropathy. minogen is activated by tissue plasminogen activator (t-PA) and urokinase (u-PA) to plasmin and produces active matrix metalloproteinase-2 (MMP-2), both of a decreased production of plasmin and hence an accumulation of intercellular matrix. Both PA and PAI-1 are expressed in the glomeruli [7] , and a delicate balance of was on antihypertensive drugs. Fundal examination was performed by ophthalmologist or physician, and diabetic which is important in the regulation of mesangial matrix turnover. Genetic variation in PAI-1 gene is associated retinopathy was defined as the presence of proliferative or background diabetic retinopathy. HbA1c was mea-with different levels of serum PAI-1 activity [8] . PAI-1 4G/4G is associated with the highest serum PAI-1 activ-sured by an automated ion-exchange chromatographic method (reference range, 5.1 to 6.4%; Bio-Rad, Her-ity and PAI-1 5G/5G with the lowest level. Moreover, recent studies also suggested a synergistic effect between cules, CA, USA). Urinary albumin concentrations were measured by immunoturbidimetry [10] . Twenty-four-RAS and PA/plasmin system in the pathogenesis of cardiovascular disease and macroangiopathy [9] . Here we hour urinary albumin excretion (UAE) was measured on three occasions during a six-week period. For patients studied the effect of PAI-1 gene polymorphisms and its synergistic effect with the ACE D/I genotype on the who were anuric (those on dialysis), all of them were macroalbuminuric at the time of diagnosis of renal dis-development of type 2 diabetic nephropathy among Chinese patients.
ease and fulfill the previously mentioned criteria of diabetic nephropathy, which are defined earlier in this article. Increased UAE was defined as a 24-hour UAE Ͼ30 METHODS mg/day on at least two of the three occasions. Microal-This was a cohort study performed in the Prince of buminuria and macroalbuminuria were defined as a Wales Hospital in Hong Kong. Type 2 diabetic patients UAE of 30 to 300 and Ͼ300 mg/day, respectively. with more than a 10-year history of disease who were followed up at the diabetes clinic or renal clinic were Angiotensin-converting enzyme gene polymorphisms assessed. We compared sex-and age-matched type 2 Genomic DNA was extracted by standard phenol/ diabetic patients with and without diabetic nephropathy, chloroform methods from peripheral blood collected on despite similar duration of disease, control of risk factors, ethylenediaminetetraacetic acid (EDTA; pH ϭ 8). The including glycemic and blood pressure control and usage ACE I/D gene polymorphism was determined by polyof ACE inhibitor. Diabetes was defined as fasting a merase chain reaction (PCR) using primers flanking the plasma sugar Ͼ7.8 mmol/L or two-hour postload plasma polymorphic region of intron 16 with the following sugar Ͼ11.1 mmol/L. Group A (N ϭ 45) consisted of primer sequences: 5Ј-CTG GAG ACC ACT CCC ATC type 2 diabetic patients with a history of more than 12
CTT TCT-3Ј and 5Ј-GAT GTG GCC ATC ACA TTC years of diabetes without diabetic nephropathy (serum GTC AGA T-3Ј. Reactions were carried out in 50 L creatinine Ͻ120 mol/L and normoalbuminuric). Group volumes under standard conditions (3 mmol/MgCl 2 , 500 B consisted of sex-and age-matched patients (N ϭ 96) mol/L for each dNTP, 10 mmol/L Tris/HCl, 50 mmol/L with diabetic nephropathy, including those on dialysis.
KCl, 0.2 mol/L primers, 1 U Taq DNA polymerase Patients were defined as having diabetic nephropathy if per sample) with a Cetus thermocycler and one-minute they had renal biopsy-confirmed diabetic nephropathy denaturing time (94ЊC), one-minute annealing time or the presence of diabetic retinopathy and neuropathy (58ЊC), and one-minute extending time (72ЊC) for a total at the onset of renal disease when they presented with of 30 cycles. Electrophoresis of the amplified products microalbuminuria or macroalbuminuria, irrespective of in 2% agarose gel allowed detection of a 190 bp fragment their renal function. Patients with renal biopsy showing (deletion) and of a 490 bp fragment (insertion). Misother types of glomerulonephritis, a history of renal typing between the DD and DI genotypes was overcome stones, a single kidney, contrast or drug-induced neby a second allele-specific PCR, which identified the phropathy, or the absence of retinopathy at the onset of presence or absence of the I allele. renal disease were excluded. Atypical features such as Plasminogen activator inhibitor-1 4G/5G promoter shrunken kidneys or significant microscopic hematuria polymorphism genotyping or those with renal disease without diabetic retinopathy were included only if the biopsy confirmed diabetic ne-Genomic DNA was extracted from peripheral blood phropathy as the sole renal disease (comprised of 10% leukocytes of all 141 type 2 diabetic patients and 95 of group B patients). Macrovascular complications are normal controls by standard techniques. PAI-1 4G/5G recorded from history. Ninety-five nondiabetic Chinese promoter genotype polymorphism was determined by subjects were used as the control.
PCR amplification of genomic DNA of all the subjects During the visits, fasting blood samples were checked using the allele-specific primers: (a) insertion 5G allele, for glucose, HbA1c, and lipids. Arterial blood pressure 5Ј-GTC TGG ACA CGT GGG GG-3Ј, and (b) deletion was measured after five minutes of rest using a standard 4G allele, 5Ј-GTC TGG ACA CGT GGG GA-3Ј. Each sphygmomanometer. Hypertension was defined as a sysin combination with a common downstream primer tolic blood pressure or diastolic blood pressure Ͼ140 5Ј-TGC AGC CAG CCA CGT GAT TGT CTA G-3Ј gives rise to a 139 bp DNA fragment. A control upstream mm Hg or 90 mm Hg, respectively, or if the patient to compare continuous data among patients with different PAI-1 genotypes. Multivariate logistic regression with two-way analysis was used for analysis of independent risk factor of diabetic nephropathy. A P value of Ͻ0.05 (two-tailed) was considered significant.
RESULTS

Characteristics of patient populations
The baseline characteristics of both groups of patients are shown in Table 1 .
They had a similar duration of diabetes mellitus, age, sex distribution, body mass index (BMI), HbA1c, prevalence of ACE inhibitor usage, and blood pressure control. All patients in group A (without diabetic nephropathy) were normoalbuminuric with normal renal function. Twenty percent (9 out of 45) of them have diabetic retinopathy. Eighty-four percent (80 out of 95) of patients in group B (with diabetic nephropathy) have diabetic retinopathy, and 43% (41 out of 95) of them required renal replacement therapy. Eighteen percent (17 out of baseline characteristics of patients with different PAI-1 genotypes ( Table 2 ). The prevalence of diabetic nephropathy is highest among patients with the PAI-1 primer 5Ј-AAG CTT TTA CCA TGG TAA CCC CTG 4G/4G genotype compared with those with the 4G/5G GT-3Ј was used as positive control in the PCR [11] .
and 5G/5G genotypes [(4G/4G), 84% vs. (4G/5G), 56% A 25 L PCR mixture contained 50 pmol allele-spevs. (5G/5G), 68%; P ϭ 0.005]. cific primer, a 50 pmol common downstream primer, a Difference in distribution of PAI-1 gene 2.5 pmol control upstream primer, 1 ϫ PCR buffer, 2.0 polymorphisms among patients with and without mmol/L magnesium chloride, 0.2 mmol/L dNTPs, and diabetic nephropathy 1.25 U Taq polymerase. All of the reagents required for PCR were purchased from Boehringer Mannheim
The allele frequencies and the genotype distribution (Mannheim, Germany). The thermal cycling conditions of the PAI-1 gene polymorphism are shown in Table 3 . were 94ЊC for 45 seconds, 67ЊC for 45 seconds, and 72ЊC
A higher prevalence of PAI-1 4G/4G genotype was obfor 75 seconds for 30 cycles. The PCR products were served among patients with diabetic nephropathy than separated by gel electrophoresis in 2% agarose gel those without [4G/4G ϭ 41% (with nephropathy) vs. (GIBCO, Grand Island, NY, USA), which had been 15% (without nephropathy), P ϭ 0.005]. The values prestained with ethidium bromide and viewed under ultravidicted by the assumption of the Hardy-Weinberg equiolet irradiation. Each subject was classified into 4G/4G, librium in both groups [(4G/4G):(4G/5G):(5G5G) ϭ 4G/5G, or 5G/5G according to the presence of the 139 36%:48%:16% (with nephropathy) vs. 23%:50%:27% bp PCR product generated by the two allele-specific (without nephropathy), P ϭ NS] were similar to those primers (Fig. 1) individuals, in patients with coronary artery disease [12] , and in patients with diabetes mellitus [13] . Besides, Dawon et al also suggested that the 4G allele is associated with an increased transcription rate in HepG2 cells under phropathy) vs. 15%:65%:20% (without nephropathy),
interleukin-1 stimulation [14] . The frequencies of PAI-1 P ϭ 0.0006]. This is also true when patients on dialysis (4G/5G) genotype and 4G allele of our Chinese diabetic were excluded from the analysis (Table 4) .
patients (4G/4G:4G/5G:5G/5G: ϭ 33%:47%:20%, 4G Synergistic effect between the ACE D allele and allele frequency ϭ 60%) were similar with that reported PAI-1 4G4G genotype on the development of in Caucasian (4G/4G:4G/5G:5G/5G: ϭ 35%:51%:14%, diabetic nephropathy 4G allele frequency ϭ 60%) and Japanese type 2 diabetic patients (4G/4G:4G/5G:5G/5G: ϭ 31%:56%:13%, 4G The distribution of different combinations of ACE allele frequency ϭ 60%) [9, 15] . (D/I) and PAI-1 (4G/5G) genotypes is shown in Table
The role of the PAI-1 genotype in the pathogenesis 5. Coexistence of ACE D allele and PAI-1 4G4G was and progression of diabetic nephropathy has recently associated with increased risk of type 2 diabetic nephropbeen addressed, and no relationship was found between athy [prevalence of 4G/4G and D allele, 22% (with ne-PAI-1 gene polymorphisms and advanced diabetic nephropathy) vs. 7% (without nephropathy), P ϭ 0.03].
phropathy among type 2 diabetic Japanese patients [9] . The difference still held when only patients with normal In our study, a higher prevalence of PAI-1 4G/4G genorenal function (Ͻ120 mol/L) were included for analysis type was found among patients with diabetic nephropa-[prevalence of 4G/4G and D allele, 36% (with nephropathy compared with a group of sex-and age-matched type thy) vs. 7% (without nephropathy), P ϭ 0.001]. The odds 2 diabetic patients with a similar duration of disease, ratio for diabetic nephropathy in patients with coexisted blood pressure, and glycemic control. This does not con-D allele and 4G/4G genotype was 1.40 (CI, 1.10 to 1.70) tradict previous findings [9] because we were studying in univariate analysis as compared with those with other the effect of PAI-1 genotypes on the prevalence of diacombinations of genotypes.
betic nephropathy, as defined by the presence of albu-Effect of PAI-1 gene polymorphisms on minuria (microalbuminuria or macroalbuminuria) rather diabetic retinopathy than the progression of diabetic nephropathy in the relationship to the renal function. The association of PAI-1 Diabetic retinopathy was highly prevalent in both 4G/4G genotype with diabetic nephropathy still upheld groups of patients with the long duration of diabetes.
when only patients with normal renal function (Ͻ120 Eighty-four percent of the patients with diabetic nemol/L) were included for analysis. This showed that phropathy had retinopathy, whereas only 20% of pathe genotype is associated with the development of albutients without significant nephropathy had retinopathy minuria, which is the hallmark of diabetic nephropathy. (P Ͻ 0.0001). There were no differences in the distribution of PAI-1 (4G/5G) genotypes between patients with Multivariate regression model analysis with HbA1C, BMI, cholesterol, hypertension, age, sex, and duration for metabolic factors such as lipids and HbA1C. Neverof diabetes controlled also confirmed that the PAI-1 theless, more studies are required to elucidate the mech-4G/4G genotype was an independent risk factor for the anism of interaction between the PAI-1 and ACE genodevelopment of nephropathy in type 2 diabetic patients.
types in disease pathogenesis in the body. The prevalence of patients on dialysis and the median The PAI-1 gene polymorphism was associated with a of serum creatinine were similar among patients with higher risk of diabetic retinopathy in Pima Indians [21] . different PAI-1 genotypes, although patients with PAI-1 However, no relationship was found between PAI-1 ge-4G/4G had a higher prevalence of diabetic nephropathy notypes and retinopathy in Caucasian diabetic patients than other genotypes (Table 2 ). This may be due to the [22] . We also failed to confirm the relationship. It is fact that the effect of PAI-1 4G/4G genotype is mainly speculative whether there is any genetic difference in on the development of diabetic nephropathy rather than Pima Indians comparing with Chinese in the effect of the progression of diabetic nephropathy. Moreover, PAI-1 gene polymorphisms on the development of retisome of the patients with PAI-1 4G/4G genotypes and nopathy. However, one of limitations of these crossadvanced renal failure may have higher premature death sectional genetic studies may be due to population adrates or a tendency to be excluded from renal replacemixture, and other study designs, for example, affected ment therapy, hence giving rise to the observed results. sib-pair analysis and transmission disequilibrium test in-The PAI-1 4G/4G genotype was found to be associated volving families affected with the disease, may be useful with an increased risk of macroangiopathy in diabetic in confirming the findings [23] . patients [15] . Our macroangiopathy rates were not differ-
The high prevalence of nephropathy in Chinese type ent among patients with different genotypes. This may 2 diabetic patients has been a heavy burden to the health be due to the limitation of a study design with potential care system because as many as 50% of type 2 diabetic selection bias caused by premature death as a result of patients were reported to have proteinuria [24], and cardiovascular or cerebrovascular events in those with many of these patients will progress to end-stage renal adverse genotypes.
failure and require dialysis. Apart from glycemic and The interaction between the PA/plasmin system and blood pressure control, genetic polymorphism probably metabolic control is intriguing. Serum PAI-1 activity is plays an important role. We found that the PAI-1 4G/4G found to be positively correlated with metabolic indices, genotype is associated with an increased risk of diabetic including fasting glucose, cholesterol, triglycerides, and nephropathy in type 2 diabetic patients, and a synergistic BMI, in type 2 diabetic patients [13, 16] . This correlation effect with the ACE D allele was also demonstrated. was strongest among the PAI-1 4G/4G genotype group.
Nevertheless, longitudinal studies are still required for Hence, patients with the PAI-1 4G/4G genotype may be further evaluation and confirmation of the findings. more susceptible to the adverse effect of unsatisfactory metabolic control than others.
